Home › Funds › ProVise Management Group, LLC › ELV

ProVise Management Group, LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

ProVise Management Group, LLC reported holding 29,275 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 0.78% of its reported portfolio and ranking #41 among its reported holdings. ProVise Management Group, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)29.27K sh
Reported value held$11.38M
Portfolio Weight0.78%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ProVise Management Group, LLC's ELV position evolved

ProVise Management Group, LLC first disclosed a stake in ELV in Q3 2023 at 16,769 shares (US$7.3M). The position peaked in Q2 2024 at 21,202 shares, worth US$11.5M. Across 13 filings, ProVise Management Group, LLC increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 29,275 shares valued at US$11.4M — an increase of 3,094 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.77K $7.30M New
Q4 2023 18.96K $8.94M Add
Q1 2024 20.77K $10.77M Add
Q2 2024 21.20K $11.49M Add
Q3 2024 21.81K $11.34M Add
Q4 2024 17.14K $6.32M Reduce
Q1 2025 20.25K $8.81M Add
Q2 2025 23.52K $9.15M Add
Q3 2025 23.07K $7.45M Reduce
Q4 2025 25.00K $8.77M Add
Q1 2026 26.18K $7.66M Add
Q2 2026 26.18K $10.12M Hold
Q3 2026 29.27K $11.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has ProVise Management Group, LLC held ELV?

ProVise Management Group, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ProVise Management Group, LLC's current position in ELV?

As of Q3 2026, ProVise Management Group, LLC holds 29.27K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $11.38M, representing 0.78% of its reported portfolio and ranking #41.

Has ProVise Management Group, LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), ProVise Management Group, LLC increased its position in ELV. The position peaked in Q2 2024 at 21.20K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.